Ticker Scorecard - AVXL Basics Company: Anavex Life Sciences Corp. IPO Date: October 7, 2015 Sector: Healthcare Industry: Biotech Market Cap: $802.16M Activated in VL: True Average Daily Range Avg Daily Range: $0.24 | 3.47% Avg Daily Range (30 D): $0.23 | 2.70% Avg Daily Range (90 D): $0.41 | 4.42% Institutional Daily Volume Avg Daily Volume: .98M Avg Daily Volume (30 D): .89M Avg Daily Volume (90 D): 1.5M Trade Size Avg Trade Size (Sh.): 160 Avg Trade Size (Sh.) (30 D): 90 Avg Trade Size (Sh.) (90 D): 107 Institutional Trades Total Inst.Trades: 1,188 Avg Inst. Trade: $1.51M Avg Inst. Trade (30 D): $1.02M Avg Inst. Trade (90 D): $1.21M Avg Inst. Trade Volume: .15M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.61M Avg Closing Trade (30 D): $1.05M Avg Closing Trade (90 D): $1.29M Avg Closing Volume: 170.25K     News Dec 27, 2024 @ 3:08 PM Anavex Life Sciences: Short-Squeeze Target Gains T... Source: Thomas Hughes Dec 23, 2024 @ 11:26 AM US Stocks To Open Higher As Wall Street Expects 'S... Source: Rishabh Mishra Nov 8, 2024 @ 11:28 PM Friday's Top 5 Trending Stocks: What's The Scoop O... Source: Erica Kollmann Sep 5, 2024 @ 12:00 PM Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwr... Source: N/A Jul 28, 2024 @ 9:00 PM Results from Anavex Life Sciences Landmark Phase I... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.55 $-.14 $-.14 Diluted EPS $-.55 $-.14 $-.14 Revenue $ 6.71M $ 1.39M $ 1.76M Gross Profit $ $ $ Net Income / Loss $ -46.49M $ -12.11M $ -11.62M Operating Income / Loss $ -55.18M $ -13.59M $ -14.34M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ M PE Ratio     Splits Oct 07, 2015:   4:1 Jun 12, 2006:   1:6